Alphagan® P 0.1% : Patient

ALPHAGAN^® P 0.1% is an eye medication that's proven to lower elevated intraocular pressure (IOP). Elevated IOP is the only risk factor that may be treated to prevent glaucomatous vision loss.

If you have been prescribed ALPHAGAN^® P 0.1%, your eye care professional has determined that you have glaucoma or ocular hypertension (elevated IOP).

Why ALPHAGAN^® P 0.1%?
Your eye care professional chose ALPHAGAN^® P 0.1% ophthalmic solution for you because:

ALPHAGAN^® P 0.1% is proven to lower IOP
ALPHAGAN^® P 0.1% offers reduced drug exposure with the lowest dose of active ingredient¹
ALPHAGAN^® P 0.1% is preserved with gentle-to-the-eyes PURITE^®¹

Indication: ALPHAGAN^® P 0.1% ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Important Safety Information
Contraindication: ALPHAGAN^® P 0.1% is contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy.
Precautions: Although ALPHAGAN^® P 0.1% ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. ALPHAGAN^® P 0.1% should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans.
Adverse reactions: Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, conjunctival hyperemia, and eye pruritus. Adverse events occurring in approximately 5% to 9% included: burning sensation, conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness, and visual disturbance.

Please click here for full product information.

1. ALPHAGAN^® P Prescribing Information.